Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat
β Scribed by M. E. Cooper; T. J. Allen; P. A. Macmillan; B. E. Clarke; G. Jerums; A. E. Doyle
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 338 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.
β¦ Synopsis
This study has evaluated the effects of the angiotensin converting enzyme inhibitor Enalapril on glomerular ultrastructure and albuminuria in normotensive and hypertensive diabetic rats. Streptozotocin-diabetes was induced in Wistar Kyoto and spontaneously hypertensive rats. Enalapril was administered in drinking water in diabetic normotensive, control hypertensive and diabetic hypertensive rats. Enalapril therapy prevented an increase in glomerular basement membrane thickness in diabetic normotensive, control hypertensive and diabetic hypertensive rats without any significant effect on fractional mesangial volume. Enalapril decreased albuminuria in diabetic normotensive, control hypertensive and diabetic hypertensive rats. Thus, enalapril retards the development of glomerular basement membrane thickening and albuminuria in the rat, in the presence or absence of hypertension.
π SIMILAR VOLUMES
## Abstract The diabeticβprone BioBreeding Wistar rat (BB/DP) is an autoimmune model of insulinβdependent diabetes mellitus. Approximately 80β90% of the animals are hyperglycemic (BB/DP~h~) by 90β120 days of age while those that do not become diabetic in adolescence (BB/DP~n~) remain normoglycemic
In the present study, we compared the effects of good blood glucose control and that of aldose reductase inhibitor (Statil) treatment on diabetic retinal capillary basement membrane thickening in the diabetic BB-rat. Aggressive insulin treatment maintaining euglycaemia for 4 months prevented the cha